Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression
Conditions: Metabolic Syndrome; Diabete Type 2; Kidney Insufficiency Interventions: Drug: Vildagliptin; Drug: Captopril Tablets; Drug: MetFORMIN 500 Mg Oral Tablet Sponsor: Cairo University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Endocrinology | Fortamet | Metabolic Syndrome | Metformin | Research | Urology & Nephrology